High RASD1 transcript levels at diagnosis predicted poor survival in adult B-cell acute lymphoblastic leukemia patients
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 80, 26-32
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81800137)
This publication has 23 references indexed in Scilit:
- Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathwayScientific Reports, 2017
- ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in de novo adult B-cell acute lymphoblastic leukemiaLeukemia Research, 2015
- ImmuSort, a database on gene plasticity and electronic sorting for immune cellsScientific Reports, 2015
- Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificityAnnals of Hematology, 2013
- Treatment of acute lymphoblastic leukemia in adultsCritical Reviews in Oncology/Hematology, 2012
- Dexamethasone-induced Ras-related protein 1 is a potential regulatory protein in B lymphocytesInternational Immunology, 2007
- Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemiaLeukemia Research, 2006
- The Ras-related protein AGS1/RASD1 suppresses cell growthOncogene, 2004
- Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer ProgramLeukemia, 2003
- Dexamethasone Rapidly Induces a Novel Ras Superfamily Member-related Gene in AtT-20 CellsJournal of Biological Chemistry, 1998